Meeting
2019 ASCO Annual Meeting
Molecular correlates of PD-L1 expression in patients with non-small cell lung cancer.
Authors
Hira Rizvi
Memorial Sloan Kettering Cancer Center, New York, NY
Hira Rizvi , Chaitanya Bandlamudi , Adam Jacob Schoenfeld , Jennifer L. Sauter , Kathryn Cecilia Arbour , Amanda Beras , Jacklynn V. Egger , Marc Ladanyi , Mark Donoghue , Charles M. Rudin , Barry S. Taylor , Matthew David Hellmann
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 37, 2019 (suppl; abstr 9018)
DOI
10.1200/JCO.2019.37.15_suppl.9018
Abstract #
9018
Poster Bd #
341
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Outcomes of single-agent PD-(L)-1 versus combination with chemotherapy in patients with PD-L1-high (≥ 50%) lung cancer.
First Author: Arielle Elkrief
Poster
2022 ASCO Annual Meeting
Molecular characterization of NF1-mutated NSCLC and clinical outcomes.
First Author: Christopher Gates
Poster
2018 ASCO Annual Meeting
Association of CDKN2A gene alteration with high expression of PD-L1.
First Author: Yan Zhang
Poster
2014 ASCO Annual Meeting
PD-L1 expression and genotype in non-small cell lung cancer (NSCLC).
First Author: Sascha Ansen